Makena
FDA Forces Unproven Premature Birth Drug Makena Off Market
The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. read more >
Sign up for Daily E-news
Sign Up
THIS WEEK’S EDITION
This Week’s Stories
View Digital Edition
EDITORS’ PICKS
Banking & Finance
Arkansas Flexes Regulatory Power With Enforcement Actions Against Financial Giants
